Idiopathic granulomatous mastitis associated with erythema nodosum may indicate a worse prognosis

Int J Rheum Dis. 2021 Nov;24(11):1370-1377. doi: 10.1111/1756-185X.14218. Epub 2021 Sep 12.

Abstract

Introduction: Idiopathic granulomatous mastitis (IGM) is a chronic inflammatory breast disease of unknown etiology, and erythema nodosum (EN) is a rare extramammary manifestation of this entity characterized by reddish, tender nodules of the lower legs. We aimed to investigate whether the association of IGM with EN has a role as a prognostic indicator. There are few case reports, and only 1 original article including 12 IGM patients with EN has been reported.

Methods: We present 43 women with IGM coexisting with EN and 43 with a diagnosis of IGM only, who were randomly selected from 610 patients for a control group. To the best of our knowledge, this paper comprises the first comparative study of the coexistence of IGM and EN to be reported in the literature.

Results: Our findings show that the association of IGM with EN indicates a more aggressive disease course. White blood cells, erythrocyte sedimentation rate, and C-reactive protein were significantly higher in the EN-positive group (P < .05). Arthralgia, breast feeding, fistula distribution and recurrence distributions were significantly higher in the EN-positive group (P < .05).

Conclusion: Since fistula distribution and recurrence rates were higher in EN-positive group, association of IGM with EN may be an indictor of a worse prognosis. The present study highlights the importance of dermatological care. All physicians should not neglect questioning breast complaints in patients with EN since EN may be caused by IGM.

Keywords: breast; corticosteroids; erythema nodosum; idiopathic granulomatous mastitis; recurrence.

MeSH terms

  • Adult
  • Cutaneous Fistula / etiology
  • Erythema Nodosum / complications*
  • Erythema Nodosum / diagnosis
  • Erythema Nodosum / therapy
  • Female
  • Granulomatous Mastitis / complications*
  • Granulomatous Mastitis / diagnosis
  • Granulomatous Mastitis / therapy
  • Humans
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome